Your browser doesn't support javascript.
loading
Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy Combination.
Al Sayed, Adher D; Elshenawy, Mahmoud A; Tulbah, Asma; Al-Tweigeri, Taher; Ghebeh, Hazem.
Affiliation
  • Al Sayed AD; Department of Medical Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Elshenawy MA; Department of Medical Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Tulbah A; Faculty of Medicine, Menoufia University, Menoufia, Egypt.
  • Al-Tweigeri T; Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Ghebeh H; Department of Medical Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Am J Case Rep ; 20: 1630-1635, 2019 Nov 06.
Article in En | MEDLINE | ID: mdl-31690713
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Paclitaxel / Triple Negative Breast Neoplasms / Immunotherapy Limits: Female / Humans / Middle aged Language: En Journal: Am J Case Rep Year: 2019 Document type: Article Affiliation country: Saudi Arabia Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Paclitaxel / Triple Negative Breast Neoplasms / Immunotherapy Limits: Female / Humans / Middle aged Language: En Journal: Am J Case Rep Year: 2019 Document type: Article Affiliation country: Saudi Arabia Country of publication: United States